Efficacy of «Gam-COVID-Vac» (Sputnik V)
https://doi.org/10.28996/2618-9801-2021-3-434-436
Abstract
For citation: Tolkach A.D., Parshina E.V., Ivanov A.V., Kislyy P.N. Efficacy of «Gam-COVID-Vac» (Sputnik V) in hemodialysis patients: a preliminary report. Nephrologу and Dialуsis. 2021; 23(3):434-436. doi: 10.28996/2618-9801-2021-434-436
About the Authors
A. D. Tolkach
Saint Petersburg State University Hospital
Russian Federation
Russian Federation
E. V. Parshina
Saint Petersburg State University Hospital
Russian Federation
Russian Federation
A. V. Ivanov
Saint Petersburg State University Hospital
Russian Federation
Russian Federation
P. N. Kislyy
Saint Petersburg State University Hospital
Russian Federation
Russian Federation
References
1. Fernando E, Govindan S. Neutralizing SARS-CoV-2 antibody response and protective effect of two doses of ChAdOx1 nCoV-19 and BBV152 vaccines in hemodialysis patients - preliminary report. Kidney Int Rep. 2021 Jul 23. doi: 10.1016/j.ekir.2021.07.009
2. Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al.; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8
Review
For citations:
Tolkach A.D., Parshina E.V., Ivanov A.V., Kislyy P.N. Efficacy of «Gam-COVID-Vac» (Sputnik V). Nephrology and Dialysis. 2021;23(3):434-436. (In Russ.) https://doi.org/10.28996/2618-9801-2021-3-434-436
Views:
40
Email this article 